09 Apr '21
LUCIRA COVID-19 All-In-One Test Kit reactive to at least 99.9% of all known COVID-19 virus strains EMERYVILLE, Calif.--( BUSINESS WIRE )--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious
04 Feb '21
EMERYVILLE, Calif.--( BUSINESS WIRE )--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the pricing of its upsized initial public offering
Displaying 11 - 14 of 14